Takeda breaks into top 20 largest pharmas with Shire merger

Takeda broke into the list of top 20 publicly traded innovative pharma companies after its $62 billion merger with Shire earlier this year, according to a new analysis using market capitalisation as a benchmark.

According to the analysis from GlobalData, Takeda’s market cap grew to $63.4 billion in Q1 this year following its takeover of Dublin-based Shire.